Smart life sciences manufacturing, often known as Pharma 4.0, aims to provide practical guidance, embed regulatory best practices, and accelerate Pharma 4.0 transformations. The main goal is to allow organizations participating in the pharmaceutical product lifecycle to control the full potential of digitalization and provide faster therapeutic innovations and improved production processes for the benefit of end-users. These changes will bring huge opportunities to life science manufacturers in the coming years. Advanced automation solutions, modern cloud-based manufacturing execution systems, augmented reality (AR), and cybersecurity are among the major aspects of Pharma 4.0. The goal of Pharma 4.0 is to achieve safer pharmaceutical production with greater efficiency along with the whole value chain. It is a highly efficient automated process driven by an integrated manufacturing control strategy. COVID-19 pandemic underlined the insufficiency of paper-based processes in the manufacturing sector across the world. Companies in this sector are looking for having real-time visibility into production processes. The pharmaceutical industry has noticed improvements after the implementation of digital and automation technologies. These factors collectively drive the smart life sciences manufacturing market growth globally.
Key stakeholders in the smart life sciences manufacturing market are hardware providers, software providers, technology enablers, regulatory bodies, system integrators/service providers, and the life sciences industry. The demand for various hardware and software solutions, along with digital transformation services, has increased in the life sciences industry due to the large-scale adoption of Pharma 4.0 in recent years. Hardware providers supply sensors, controllers, and various other components, which allow for the digital transformation of the life sciences manufacturing plants. Software providers supply various solutions that facilitate connections between hardware components and aid in data collection and storage in life sciences manufacturing plants. Technology enablers play a crucial role in the rising adoption of Pharma 4.0 solutions, as they provide platforms to host different solutions. Regulatory bodies ensure that the solutions being used in life sciences research and manufacturing comply with regulations. System integrators/service providers are third parties that aid in developing, customizing, integrating, and maintaining different smart manufacturing solutions in pharmaceutical and medical device manufacturing plants and laboratories. The life sciences industry is the end user of the various solutions and services pertaining to smart manufacturing.
Read More: https://www.theinsightpartners.com/reports/smart-life-sciences-manufacturing-market